About us
What we are
Management
Scientific Advisory Board
Where to find us
About you
What we look for
What you should know


Our business
Portfolio companies
Latest news


Login for investors

Sunesis' Voreloxin granted Orphan drug designation by FDA
November, 2009

Download Article

back